Automation Pro Says India Pharmas Need To Automate More
This article was originally published in PharmAsia News
Executive Summary
The head of an automation industry group says increased competition from China should lead Indian drug makers to step up automation of their manufacturing processes. The president of the Automation Industry Association said Indian pharmaceuticals were modernizing in other ways as they expand to global markets, but automation still is not a priority. The AIA leader said automation could become the key factor in competition. The chairman of Pharmexcil said maintenance costs and lack of timely service discouraged changeover. (Click here for more